Y. Zhang et al., ESTROGEN-INDUCED KERATINOCYTE GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN NORMAL AND CANCEROUS HUMAN BREAST CELLS, Oncology Reports, 5(3), 1998, pp. 577-583
The local recurrence rate of breast cancer has been reported to be unu
sually high at the surgical scar. Such breast cancer recurrence is bel
ieved to be triggered by the release of growth factors into the healin
g wound. Observations from an animal model have also demonstrated that
KGF expression is dramatically induced by creation of full thickness
wounds in mouse skin. Since KGF is an epithelial cell-specific mitogen
in rat mammary epithelium, it is reasonable to speculate that KGF may
be also involved in regulating human breast cancer cell growth. The p
urpose of the present study was to determine the effect of estradiol-1
7 beta on KGF gene expression in normal human breast stromal cells, as
well as in human breast cancer stromal cells, and the mechanisms by w
hich estradiol-17 beta regulates breast epithelial proliferation. Our
results show that KGF expression was not effected by estradiol-17 beta
treatment in normal human breast stromal cells. In contrast, KGF expr
ession was stimulated by estradiol-17 beta in human breast cancer stro
mal cells. KGF mRNA levels have also been examined in normal human bre
ast stromal cells and human breast cancer stromal cells. An interestin
g correlation was found between KGF expression and estradiol-17 beta r
egulation in these cell types. Normal human breast stromal cells which
do not response to estradiol-17 beta have lower KGF mRNA level than t
he cancer cells which KGF expression is stimulated by estradiol-17 bet
a. Our data also demonstrate that recombinant human KGF significantly
stimulate normal human breast and human breast cancer epithelial cell
proliferation in a dose-dependent manner. Since we have shown that est
radiol-17 beta induces KGF mRNA expression in human breast cancer stro
mal cells, KGF may be involved at least in part in the stimulatory pat
hway that is initiated by estradiol-17 beta in human breast cancer epi
thelial cells.